GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million

1 month ago 34
Under the deal, Alfasigma volition summation rights to develop, manufacture and commercialize linerixibat.
Read Entire Article
  1. Homepage
  2. Health
  3. GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million

Related

Trump Withdraws Nomination of Casey Means for Surgeon General

Trump Withdraws Nomination of Casey Means for Surgeon Genera...

10 hours ago 1
Mother and baby mental health unit to go ahead

Mother and baby mental health unit to go ahead

11 hours ago 1
Eli Lilly cemented its lead in the booming weight-loss drug market with huge sales gains for the first quarter, as focus shifts to new pills

Eli Lilly cemented its lead in the booming weight-loss drug ...

11 hours ago 1

Popular

The Trump administration announced criminal charges, sanctions and multimillion-dollar rewards aimed at combating online scams coming out of Southeast Asia and targeting Americans

The Trump administration announced criminal charges, sanctio...

6 days ago 24
The president called it the “hottest ticket in town.” Then a gunman charged a security checkpoint at the White House Correspondents’ Dinner.

The president called it the “hottest ticket in town.” Then a...

4 days ago 20
31 Sloths Acquired by an Orlando Animal Attraction Died, Officials Say

31 Sloths Acquired by an Orlando Animal Attraction Died, Off...

6 days ago 17
If you have aortic stenosis and need to have your heart valve replaced, here are two options to know about

If you have aortic stenosis and need to have your heart valv...

5 days ago 16
'Empower young people to be bold conservationists'

'Empower young people to be bold conservationists'

6 days ago 15
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved